• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Introduction to 5-(4-Methylpiperidin-1-yl)pyridin-2-amine and Its Significance in Modern Chemical Research

5-(4-Methylpiperidin-1-yl)pyridin-2-amine, a compound with the CAS number 866620-33-9, represents a fascinating molecule in the realm of pharmaceutical chemistry. This compound, characterized by its intricate structural framework, has garnered significant attention due to its potential applications in drug discovery and development. The unique combination of a piperidine ring and a pyridine moiety, along with the amine functional group, makes it a versatile scaffold for designing novel therapeutic agents.

The structural features of 5-(4-Methylpiperidin-1-yl)pyridin-2-amine contribute to its remarkable chemical properties. The presence of the methylpiperidine substituent enhances its solubility and bioavailability, which are critical factors in pharmaceutical formulations. Furthermore, the pyridine ring introduces a hydrogen bond acceptor site, facilitating interactions with biological targets. These characteristics have positioned this compound as a promising candidate for further exploration in medicinal chemistry.

In recent years, there has been growing interest in the development of small molecule inhibitors targeting various biological pathways. 5-(4-Methylpiperidin-1-yl)pyridin-2-amine has been identified as a potential lead compound in several research studies aimed at modulating enzyme activity and receptor binding. Its ability to interact with multiple targets makes it an attractive candidate for the development of multifunctional drugs.

One of the most compelling aspects of 5-(4-Methylpiperidin-1-yl)pyridin-2-amine is its role in addressing unmet medical needs. Current research indicates that this compound exhibits inhibitory activity against several enzymes involved in inflammatory and metabolic disorders. The ability to modulate these pathways could lead to the development of novel therapeutics that offer improved efficacy and reduced side effects compared to existing treatments.

The synthesis of 5-(4-Methylpiperidin-1-yl)pyridin-2-amine involves a series of well-defined chemical transformations that highlight the ingenuity of modern synthetic methodologies. The process typically begins with the functionalization of a pyridine precursor, followed by the introduction of the piperidine moiety. The final step involves the incorporation of the amine group, which is achieved through various coupling reactions. These synthetic strategies not only showcase the versatility of organic chemistry but also demonstrate the importance of precision in molecular construction.

Recent advancements in computational chemistry have further enhanced our understanding of 5-(4-Methylpiperidin-1-yl)pyridin-2-amine's behavior. Molecular modeling studies have provided valuable insights into its binding interactions with biological targets, allowing researchers to optimize its structure for improved pharmacological properties. These computational approaches complement traditional experimental methods, offering a more comprehensive view of the compound's potential applications.

The pharmacological profile of 5-(4-Methylpiperidin-1-yl)pyridin-2-amine is another area of intense investigation. Preclinical studies have demonstrated its ability to inhibit key enzymes such as kinases and phosphodiesterases, which are implicated in various diseases. The compound's selectivity profile is particularly noteworthy, as it exhibits high affinity for target enzymes while minimizing off-target effects. This selectivity is crucial for developing drugs with enhanced therapeutic index.

In conclusion, 5-(4-Methylpiperidin-1-yl)pyridin-2-amine represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising pharmacological properties make it an invaluable tool for drug discovery and development. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in addressing some of the most pressing medical challenges faced today.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)